-
Document de presse | 2018.07.25
Benefits of early antiretroviral therapy in HIV-infected children
The initial findings of the ANRS CLEAC[1] study[2] coordinated by Pierre Frange (Hôpital Necker – AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France. The results of this study will be presented by Florence Buseyne (Oncogenic Virus Epidemiology & Pathophysiology Team - Institut Pasteur) this Wednesday, 25...
-
Report | 2018.07.27
Ebola, plague, cholera, SARS… Emerging pathogens, an unpredictable threat
One hundred years after the deadliest influenza pandemic in history – the Spanish Flu of 1918 –, emerging and re-emerging infectious diseases continue to represent a major threat to public health worldwide. As the international Emerging Infections and Pandemic Risk conference was held at the Institut Pasteur on June 21 and 22, the recent Ebola outbreak in the Democratic Republic of the Congo came...
-
Document de presse | 2018.08.22
Chronic malnutrition in children: a new gut microbial signature
Chronic malnutrition, usually associated with an inflammation of the small intestine, affects one in every four children under the age of five. It is the leading cause of child mortality in low-income countries and is also responsible for severe stunting. The Afribiota project, led by the Institut Pasteur in Paris, the Institut Pasteur in Madagascar and the Institut Pasteur in Bangui, in...
-
News | 2018.09.05
Meriem Ben Ali : a better diagnosis for immune deficiencies in Tunisia
Primary immunodeficiencies cause immune system anomalies in those affected, preventing an optimal defense against pathogens. These diseases linked to genetic anomalies are especially common in Tunisia owing to a high rate of consanguinity. Facing up with these pathologies, Dr. Meriem Ben Ali conducts research in the Transmission, Control and Immunobiology of Infections Laboratory of the Institut...
-
Document de presse | 2018.09.05
Genetic control of human thymic function : a needle in an haystack
A study conducted by a group of researchers from Paris Diderot University, Inserm and the Institut Pasteur reveals the existence of a genetic factor influencing the function of the human thymus. The results of the study, part of the Laboratories of Excellence project Milieu Intérieur coordinated by the Institut Pasteur, are published in the journal Science Translational Medicine on September 5,...
-
News | 2018.09.07
Lyme disease: a study on the speed of transmission by infected ticks
Lyme borreliosis is a disease caused by bacteria of the genus Borrelia that are transmitted by a bite from a tick of the genus Ixodes. Scientists from the Institut Pasteur used mice to study the transmission of bacteria by ticks infected with various European and North American species of Borrelia. They found evidence of rapid bacterial transmission following a bite, with infection occurring...
-
Report | 2018.09.13
How big data is revolutionizing health research
Identifying risk factors for disease, helping diagnose cancer, guiding therapeutic choices and monitoring the efficacy of treatment, facilitating surveillance of pathogens – in a huge number of fields, technological progress is now providing biomedical research with vast reams of information (or "big data") about the diseases under study, representing an extraordinary source of new knowledge and...
-
News | 2018.09.17
Hepatitis B: to better identify patients eligible for treatment in Africa
Today, hepatitis B can be efficiently treated but the diagnosis tools to assess treatment eligibility are complex and their availability is scarce in Africa. To identify these patients, researchers from the Institut Pasteur in Paris and the Institut Pasteur de Dakar have developed a simple and efficient method that could easily be implemented in resource-limited countries.In 2016, WHO set up...
-
Document de presse | 2018.09.13
With its new "Omics" buildings, the Institut Pasteur continues its digital revolution
The new "Omics" buildings, inaugurated today at the Institut Pasteur, will house outstanding multidisciplinary research teams and state-of-the-art technologies to explore the myriad possibilities offered by the development of computational biology, with the aim of strengthening our ability to tackle the scientific and health challenges of the 21st century. This center of expertise, unique in...
-
News | 2018.09.12
A debate on sepsis at the Institut Pasteur
On September 12, the Institut Pasteur hosted a debate entitled "Sepsis – uniting to tackle a little-known threat", under the aegis of the French Ministry for Solidarity and Health. Sepsis is the term used internationally to describe a systemic inflammatory response to severe infection. As well as raising awareness of this unknown disease, the debate highlighted the measures taken by the French...
